Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B ...Middle East

PR Newswire - News
Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
Inhibrx, Inc. shareholders will receive per share consideration of $30 per share in cash, a CVR equal to $5, plus 0.25 shares in New Inhibrx, a new publicly traded company that retains all non-101 assets of Inhibrx, Inc. Sanofi to pay off Inhibrx's outstanding debt balance and capitalize...

Hence then, the article about inhibrx announces sale of inbrx 101 to sanofi for an aggregate value of up to 2 2b was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B )

Apple Storegoogle play

Last updated :

Also on site :



Latest News